N6-(2-Hydroxyethyl)adenosine

CAS No. 4338-48-1

N6-(2-Hydroxyethyl)adenosine( —— )

Catalog No. M37892 CAS No. 4338-48-1

N6-(2-Hydroxyethyl)adenosine, a Ca2+ antagonist and anti-inflammatory agent, is associated with the regulation of cerebral and coronary circulation and is believed to exhibit sedative activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 34 In Stock
50MG 30 In Stock
100MG 45 In Stock
200MG Get Quote In Stock
500MG 100 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N6-(2-Hydroxyethyl)adenosine
  • Note
    Research use only, not for human use.
  • Brief Description
    N6-(2-Hydroxyethyl)adenosine, a Ca2+ antagonist and anti-inflammatory agent, is associated with the regulation of cerebral and coronary circulation and is believed to exhibit sedative activity.
  • Description
    N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4338-48-1
  • Formula Weight
    311.29
  • Molecular Formula
    C12H17N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.?
molnova catalog
related products
  • ACT 709478

    ACT 709478 is a potent, selective, orally-bioavailable, brain penetrant T-type calcium channel blocker with IC50 of 6.4, 18, and 7.5 nM for Cav3.1, Cav3.2, and Cav3.3 channels respectively.

  • Sipatrigine

    Sipatrigine (619C89) is an antiepileptic compound with neuroprotective activity through glutamate release, TREK ion channels, TRESK channels, sodium channels, and calcium channel inhibitors in the CNS, and can be used to study TRESK channels.

  • Dantrolene sodium he...

    Dantrolene is a postsynaptic muscle relaxant that lessens excitation-contraction coupling in muscle cells.